Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Tethis S.p.A logo — company profile

Tethis S.p.A

Founded 2004 Italy Italy 31 employees Grant Total: $71.43K Biotechnology

General Information

Company Name Tethis S.p.A
Founded Year 2004
Location Italy Italy
Founders / Decision Makers
Team member Team member
Employees 31
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Tethis S.p.A. To contact Tethis S.p.A, visit tethis-lab.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tethis S.p.A compare?

A PDF of Tethis S.p.A and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tethis S.p.A soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tethis S.p.A

Tethis S.p.A is a biotechnology startup based in Italy that was founded in 2004. The company aims to revolutionize oncology diagnostics by making liquid biopsy a standard, reproducible practice. Their proprietary slides enable immediate, fully automated, and gentle processing of blood samples, addressing crucial unmet needs for standardization and maintaining clinical informativity. Tethis focuses on conducting high throughput analytical protocols for highly sensitive and specific blood-based cancer testing in various clinical settings. Their most recent investment was a €71.43K Grant investment received on 01 May 2018, with the details of the investors undisclosed at this time. Tethis's innovative approach to liquid biopsy and cancer testing presents a compelling proposition for potential investors in the biotechnology sector.

Business keywords: liquid biopsy, oncology diagnostic, proprietary slides, blood samples processing, clinical informativity, high throughput analytical protocols, cancer testing, clinical settings

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €71.43K -
01 May 2018
Venture Round Undisclosed 1
Atlante Ventures
28 Feb 2014
Venture Round Undisclosed 1
Atlante Ventures
28 Feb 2013
Venture Round Undisclosed 1
Atlante Ventures
28 Sep 2012
Venture Round Undisclosed 1
Atlante Ventures
15 Feb 2012
Venture Round Undisclosed 1
IMI Fondi Chiusi SGR
IMI Fondi Chiusi SGR
26 May 2010

Tethis S.p.A Alternatives & Competitors

View All Alternatives
Tethis S.p.A vs
Biocept, Inc.
Biocept, Inc. United States

Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic...

Post-IPO Equity
49 employees
Biotechnology, Health Care
Compare Tethis S.p.A vs Biocept, Inc.
Tethis S.p.A vs
LCM Genect
LCM Genect Italy

Enable precision medicine

6 employees
Biopharma, Biotechnology
Compare Tethis S.p.A vs LCM Genect
Tethis S.p.A vs
Exosome Diagnostics, a Bio-Techne brand
Exosome Diagnostics, a Bio-Techne brand United States

ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and gu...

Series C
103 employees
Biotechnology, Health Care
View all alternatives

FAQ About Tethis S.p.A

At Tethis we aim to make liquid biopsy a standard, reproducible, oncology diagnostic. Our proprietary slides allow immediate, fully automated and gentle processing of blood samples, three unaddressed elements that are crucial to ensure standardization and to maintain clinical informativity. High thr...
Tethis S.p.A was founded in 2004.
Tethis S.p.A is headquartered in Italy.
Tethis S.p.A operates in Biotechnology. Its work centres on liquid biopsy, oncology diagnostic, proprietary slides and blood samples processing.
Tethis S.p.A has approximately 31 employees.
Tethis S.p.A has completed 6 funding rounds, raising a total of $71.43K. The latest funding stage is Grant.
Top alternatives and competitors to Tethis S.p.A include Biocept, Inc. , LCM Genect, Exosome Diagnostics, a Bio-Techne brand, Vortex Biosciences, Biodesix, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tethis S.p.A and Biocept, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tethis S.p.A, https://bouncewatch.com/company/tethis-spa, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout